SCANPHARM A/S: Financial statements 2022
CVR: 16279099
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 17,399,136 and a net result of DKK -5,954,451 compared with DKK -10,870,586 the year before. That is an increase of 54.5% compared with the year before. Equity in the 2022 report amounted to DKK 1,500,000. The solvency ratio was 5.1%. The company had 41 employees in the financial year.
- Gross Profit
- DKK 17,399,136
- Profit/Loss
- DKK -5,954,451
- Equity
- DKK 1,500,000
- Total Assets
- DKK 29,659,019
- Employees
- 41
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 17.4 mio. | -6 mio. | 1.5 mio. | 41 |
| 2021 | - | 11.3 mio. | -10.9 mio. | 1.5 mio. | 40 |
| 2020 | - | 5.1 mio. | -18.9 mio. | 1.9 mio. | 40 |
| 2019 | - | 17.8 mio. | -4 mio. | 5.9 mio. | 42 |
| 2018 | - | 19.6 mio. | -2.9 mio. | 9.9 mio. | 46 |
Official annual report
Keep an eye on SCANPHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
SCANPHARM A/S has published its annual report for 2021. Gross profit came to DKK 11,259,429, and the net result was DKK -10,870,586.
As of January 6, 2022, Janus Doré Pagh has joined the board of directors of SCANPHARM A/S.
As of January 6, 2022, Holger Carsten Hansen has left the board of directors of SCANPHARM A/S.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 42 employees (2026). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.